Source link : https://newshealth.biz/health-news/teplizumab-approval-expands-to-early-type-1-diabetes/
The FDA expanded the approval of teplizumab (Tzield) to include pediatric patients 8 years and older who have recently been diagnosed with stage 3 type 1 diabetes, the clinical stage where hyperglycemia symptoms emerge and insulin therapy is needed. An anti-CD3 antibody, teplizumab is indicated to delay the decline of insulin production and is believed […]
The post Teplizumab Approval Expands to Early Type 1 Diabetes first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-15 14:40:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8